Please assess the completion status of the following clinical trial:

Trial Title: Providing Suboxone and PrEP Using Telemedicine

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* History of self-report injection opioid use in the past 6 months~* Participate in SSPs,~* HIV negative~* Willing to take bup/nx and PrEP for 6 months~* No medical contraindications for these medications~* Not pregnant~* 18 years or older~* Not currently taking PrEP~* Not currently taking any form of MOUD~* History of sharing injection or drug preparation equipment or risk of sexual acquisition of HIV (such as engaging in sex work or men who have sex with men) in the past 6 months~Exclusion Criteria:~* Positive pregnancy test including during the course of the study~* Positive HIV test at enrollment~* Altered mental status in which participant cannot sign a consent form~* Renal insufficiency/failure~* Hepatitis B surface antigen positive~* Becoming incarcerated during the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Medication and telemedicine follow up (Type: EXPERIMENTAL): All participants are provided with Suboxone and/or PrEP and follow up visits will be conducted via telemedicine

Based on this trial design, predict the completion outcome and termination type (if applicable).